Tobacco Use Disorder: all 988 studies
Page 9 of 10. Open to participants first (124), then studies with results posted, then the rest; newest registration first within each.
- Direct to Smoker Outreach in a Health Care SettingCompletedNCT01321944Not applicable
- Multiple-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement ProductsCompletedNCT01321931Phase 1
- Effects of Intensive Behavioral Training Program on Impulsivity and Inhibitory Control in SmokersStatus unknownNCT01314378Not applicable
- Evaluation of a Combined Parent-student Programme for Smoking Prevention in Berlin SchoolsStatus unknownNCT01306552Not applicable
- A Follow-up Study to Assess Long-term Immunogenicity and Safety of NicVAX/Placebo as an Aid to Smoking CessationCompletedNCT01304810
- Pilot Randomized Control Trial of Financial Incentives for Smoking CessationCompletedNCT01303081Not applicable
- Smoking-induced Dopamine Release: a [11C]-(+)-PHNO PET Study in HumansCompletedNCT01302262
- A Pilot Study to Evaluate Safety and Efficacy of CigRx™ in SmokersCompletedNCT01262170Phase 1
- De-nicotinised Cigarettes StudyCompletedNCT01250301Not applicable
- Nicotinic Modulation of the Default Network of Resting Brain FunctionCompletedNCT01240616
- Bioequivalence Between Two Oral Nicotine Sublingual Tablets, 2 mg and 4 mgCompletedNCT01238627Not applicable
- Single-dose Nicotine Pharmacokinetics With Four Oral Nicotine Replacement ProductsCompletedNCT01234896Not applicable
- Single-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement Products. A Study in Healthy Smokers.CompletedNCT01234792Not applicable
- Baclofen for Smoking Cessation in a Non-Psychiatric PopulationTerminatedNCT01228994Phase 2
- Single-dose Pharmacokinetics of Oral Nicotine Replacement ProductsCompletedNCT01228617Not applicable
- Comparative Pharmacokinetic Study of New Oral Nicotine Replacement Therapy Products.CompletedNCT01227720Not applicable
- Smoking Abstinence and Lapse Effects in Smokers With Schizophrenia and ControlsCompletedNCT01214005Phase 2
- Safety, Tolerability and Efficacy of the Nicotine Patch and Gum for the Treatment of Adolescent Tobacco DependenceCompletedNCT01208935Phase 2/3
- Tailoring Varenicline to Individual Needs (TVIN Study)CompletedNCT01206010Phase 3
- Medications Development for the Treatment of Cannabis Related DisordersCompletedNCT01204723Phase 1
- Testing Counseling Styles to Motivate Smokers to QuitCompletedNCT01188018Phase 3
- Brain Activity and Smoking CessationCompletedNCT01186055
- Combination of Nicotine Replacement Therapy (NRT) and Varenicline to Increase Cessation of Tobacco (CONVICT Study)CompletedNCT01184664Phase 3
- Examining a Text Message Intervention for Smoking CessationCompletedNCT01166464Not applicable
- Bioequivalence Between an Oral Nicotine Replacement Product and Nicorette® GumCompletedNCT01152749Not applicable
- Pharmacokinetics With a New Oral Nicotine Replacement Product and Nicorette® GumCompletedNCT01152736Not applicable
- Pharmacokinetics With Two New Oral Nicotine Replacement Products and Nicorette® GumCompletedNCT01152723Not applicable
- Effects of Smoking Cues on Tobacco Craving Responses and the Reinforcing Efficacy of Cigarettes in Adolescent SmokersCompletedNCT01148355
- Mindfulness Training for Smoking CessationCompletedNCT01144689Not applicable
- Smoking Termination Opportunity for inPatientsCompletedNCT01141855Phase 2/3
- Assessing Top Down and Bottom Up Attention Mechanisms in Smokers Using Nicotine Nasal SprayCompletedNCT01136642Phase 1
- Alcohol Counseling for Telephone Quitline CallersCompletedNCT01120080Phase 1/2
- Bioequivalence Between Nicotine Replacement Products and Nicorette® GumCompletedNCT01113424Not applicable
- Study of Varenicline (Champix) for Smoking Cessation/Reduction in Patients With Bipolar DisorderCompletedNCT01093937Not applicable
- Novel Determinants and Measures of Smokeless Tobacco Use: Study 2CompletedNCT01067599Not applicable
- QuitAdvisorMD: A Point-of-care Tool for Brief Smoking Cessation InterventionsStatus unknownNCT01065493Phase 2
- Investigation of Cycloserine as a Smoking Cessation TreatmentCompletedNCT01062932Phase 1
- The Neural Basis of Cue-Elicited Cigarette Craving and Its ControlCompletedNCT01048957Not applicable
- The Effect of Exercise on Acute Nicotine WithdrawalCompletedNCT01047930Not applicable
- fMRI Study of Nicotinic Effect on Neurophysiology of SchizophreniaCompletedNCT01046526
- PET Imaging of Nicotinic Acetylcholine ReceptorsCompletedNCT01046513
- Effects of Nicotine on Brain Opioid ReceptorsTerminatedNCT01040338
- p16 Methylation for Smoking CessationCompletedNCT01038492Not applicable
- Quantitation of Human Cerebral Nicotinie Receptors With 2[18F]FA-85380 and PET Healthy Non-smokers and Ex-Smokers and in Heavy and Light Situational SmokersCompletedNCT01038245
- Effects of Nicotine on Brain Activity as Measured by fMRICompletedNCT01037153
- Effects of Nicotine on Cognitive Task Performance and Brain Activity as Measured by fMRICompletedNCT01036711
- Cognitive Task Development and Implementation for Functional MRI StudiesCompletedNCT01036685
- Effects of Nicotine on Areas of Impaired and Preserved Functioning in SchizophreniaCompletedNCT01034085
- Effects of Nicotine on Elements of Attentions in Smokers and NonsmokersCompletedNCT01034020Phase 1
- Pilot Study of Transcranial Magnetic Stimulation (TMS) in Nicotine AddictionCompletedNCT01031693Phase 1
- Assessment of Craving in Nicotine-Dependent Patients With Schizophrenia Using Virtual RealityCompletedNCT01031433
- Breath Carbon Monoxide and Cotinine as Biomarkers to Distinguish Smokers From NonsmokersCompletedNCT01031121
- Screening Protocol for Research ParticipantsCompletedNCT01010620
- Varenicline for Long-term Nicotine Replacement Therapy (NRT) UsersStatus unknownNCT00977249Phase 2/3
- Sensitivity to Intravenous Nicotine: Genetic ModeratorsCompletedNCT00969137Phase 1
- Effects of Chantix on Relapse Prevention for Smoking CessationCompletedNCT00948649Phase 4
- Exercise or Relaxation for Smoking CessationCompletedNCT00921388Not applicable
- Efficacy and Safety of Varenicline Among HIV-infected PatientsCompletedNCT00918307Phase 3
- Biomarkers for Early Detection of Lung Cancer in Patients With Lung Cancer, Participants at High-Risk for Developing Lung Cancer, or Healthy VolunteersStatus unknownNCT00899262
- Effect of Varenicline on Reactivity to Smoking and Drinking CuesCompletedNCT00873535Not applicable
- Airway Macrophages and Sputum Milieu in Adult Subjects With Airflow ObstructionCompletedNCT00871637
- Computer-Assisted Stop-Smoking Program in Helping Doctors Counsel Patients Who Smoke CigarettesStatus unknownNCT00865553Phase 2
- Prize Reinforcement for Smoking CessationCompletedNCT00865254Not applicable
- Cue Induced Imaging in Nicotine Dependent SmokersCompletedNCT00844701
- Extinction Based Treatment for Nicotine DependenceCompletedNCT00831155Phase 1
- A Multi-Modal Investigation of the Smoking Cessation Medication Varenicline: Dopaminergic Modulation of Reward Processing and Cognitive ControlCompletedNCT00830739
- Effectiveness of a Web-Assisted Quitline for Smokeless Tobacco UsersCompletedNCT00820495Phase 2
- Drug /Cue Interactions In Alcohol-Tobacco ComorbidityCompletedNCT00816231Not applicable
- Cancer Risk Reduction Through Combined Treatment for Tobacco and Alcohol UseStatus unknownNCT00799669
- Treating Schizophrenic Smokers: Effects on Craving, Cues and WithdrawalWithdrawnNCT00781755Phase 4
- Comparisons of Nicotine-free Cigarettes, Extra Low Nicotine Cigarettes vs. Medicinal NicotineCompletedNCT00777569Phase 2
- Effects of Smoking Cues on Tobacco Craving Responses and the Reinforcing Efficacy of Cigarettes in Smokers With and Without SchizophreniaCompletedNCT00770237Not applicable
- Screening Methods in Finding Lung Cancer Early in Current or Former SmokersStatus unknownNCT00751660Not applicable
- N-Acetylcysteine and Smoking ReductionCompletedNCT00751257Phase 2
- Acute Effects of Smoking on Airway Dendritic CellsCompletedNCT00740896Not applicable
- Varenicline Treatment in Alcohol and Nicotine Dependent Patients With SchizophreniaCompletedNCT00727103Phase 4
- Behavioral Exercise Intervention for Smoking CessationCompletedNCT00713063Phase 2
- School Nurse-Delivered Smoking Cessation InterventionCompletedNCT00682474Phase 2/3
- Smoking Interventions in General Medical PracticesStatus unknownNCT00679861Phase 2
- Tobacco Zero: Interactive Tobacco Education for TeensCompletedNCT00670995Phase 2
- Randomized Trial Assessing the Effectiveness of a Pharmacist-Delivered Program for Smoking CessationCompletedNCT00670904Not applicable
- Clinical Effort Against Secondhand Smoke (CEASE) Program or Standard Care in Helping Parents Stop SmokingCompletedNCT00664261Not applicable
- Quitline Use in Surgical PatientsCompletedNCT00656500Not applicable
- GABA (Gamma Amino Butyric Acid) Medication for TobaccoCompletedNCT00644137Early Phase 1
- Dental Tobacco Control.Net:Improving PracticeCompletedNCT00627185Early Phase 1
- Treating Tobacco Dependence in Adolescents With Co-occurring Psychiatric DisordersCompletedNCT00618943Phase 3
- Social Cognition,Attentional Network and Nicotine Drug Dependency - A Pharmacological Clinical TrailCompletedNCT00618280Phase 1/2
- Green Tea Extract in Treating Current or Former Smokers With Bronchial DysplasiaTerminatedNCT00611650Phase 2
- Tobacco Use Intervention Among Radiation Oncology PatientsCompletedNCT00587353Phase 2
- Green Tea Extract in Preventing Cancer in Former and Current Heavy Smokers With Abnormal SputumCompletedNCT00573885Phase 2
- Study of Varencline Effects on Cigarette Smoking Reward and Craving During a Model of Brief Quit AttemptWithdrawnNCT00571805Phase 1/2
- A Study of Naltrexone SR/ Bupropion SR in Overweight and Obese Subjects Who Are Nicotine-DependentCompletedNCT00563563Phase 2
- Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral CancerActive, not recruitingNCT00542373Not applicable
- Physical Activity as an Aid for Smoking CessationTerminatedNCT00521391Phase 3
- Examining a New Biomarker of Nicotine Use Among Pregnant Women Who Participated in the New England SCRIPTCompletedNCT00519766
- Contingency Management for Smoking Cessation Among Veterans With Psychotic DisordersTerminatedNCT00508560Not applicable
- Reducing Ethnic Health Disparities: Motivating HIV+ Latinos to Quit SmokingCompletedNCT00503230Phase 3
- Tobacco Use in Opioid Agonist Treated Pregnant WomenCompletedNCT00497068Phase 2/3
- The Pharmacogenetic Study , Readiness to Change, and Pharmacological Intervention for Smoking Cessation in SchizophreniaCompletedNCT00495352Phase 4
- Randomized Trial of Ultrashort Psychotherapy vs Sustained-Release Bupropion for Smoking CessationCompletedNCT00484692Phase 4